Search
Search
About
Log in
Join
Experiences with
Daratumumab
Posts
Communities
6 public posts
Filter results
CD38
Perhaps we will be hearing more about
Daratumumab
( Darzalex).
Perhaps we will be hearing more about
Daratumumab
( Darzalex).
pjoshea13
in
Advanced Prostate Cancer
3 years ago
New type of treatment could reawaken immune response against prostate cancer
Targeting CD38 Their study suggests that therapies which target CD38 – such as the multiple myeloma drug
daratumumab
– could hold promise against prostate cancer too, by reawakening the anti-cancer immune response.
Targeting CD38 Their study suggests that therapies which target CD38 – such as the multiple myeloma drug
daratumumab
– could hold promise against prostate cancer too, by reawakening the anti-cancer immune response.
TottenhamMan
in
Advanced Prostate Cancer
3 years ago
TREATMENT UPDATE: Daratumumab (also known as Darzalex®) recommended across Europe in new combinations for myeloma patients.
The Committee of Human Medicinal Products in Europe is recommending that
daratumumab
(also known as Darzalex®) has its licence extended to include combination treatments for myeloma patients. It's already licensed in Europe for use on its own.
The Committee of Human Medicinal Products in Europe is recommending that
daratumumab
(also known as Darzalex®) has its licence extended to include combination treatments for myeloma patients. It's already licensed in Europe for use on its own.
Myeloma-UK
in
Myeloma UK
7 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
SMC say “no” to Kyprolis® and Darzalex® for myeloma patients in Scotland
Scotland's drug approval body has decided not to recommend both Kyprolis® (carfilzomib) and Darzalax® (
daratumumab
) for myeloma patients. Myeloma UK made a strong case to the SMC and we are very disappointed by the decision.
Scotland's drug approval body has decided not to recommend both Kyprolis® (carfilzomib) and Darzalax® (
daratumumab
) for myeloma patients. Myeloma UK made a strong case to the SMC and we are very disappointed by the decision.
RebeccaJardine
in
Myeloma UK
7 years ago
Can High-Risk Myeloma Patients Become Refractory to Certain Monoclonal Antibodies?
Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to
daratumumab
?” Dr.
Patient Power Community member, Francis, asks “Can refractory, high-risk myeloma patients become refractory to
daratumumab
?” Dr.
mcints
in
Myeloma America Support
8 years ago
Daratumumab Drug Trial
Hello I was wondering if anyone has heard of a new drug (I think) called
Daratumumab
. There was a small piece in the newspaper (Perth WA) regarding this new drug, saying that "it has produced excellent results for patients, with an incurable blood cancer, with many expected to go into remission.
Hello I was wondering if anyone has heard of a new drug (I think) called
Daratumumab
. There was a small piece in the newspaper (Perth WA) regarding this new drug, saying that "it has produced excellent results for patients, with an incurable blood cancer, with many expected to go into remission.
cheridiane
in
MPN Voice
9 years ago
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
2 results
Myeloma UK
2 results
MPN Voice
1 result
View top 10 communities
Sort by
Most Relevant
Newest